FAIM
RMD icon

Financial Advocates Investment Management’s ResMed RMD Stock Holding History

Financial Advocates Investment Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,193
Closed -$566K – 473
2025
Q2 		$566K Sell
2,193
-379
-15% -$90.4K 0.05% 334
2025
Q1 		$576K Buy
2,572
+36
+1% +$8.4K 0.04% 397
2024
Q4 		$580K Sell
2,536
-115
-4% -$27.7K 0.03% 412
2024
Q3 		$647K Sell
2,651
-157
-6% -$35.1K 0.04% 398
2024
Q2 		$537K Buy
2,808
+513
+22% +$104K 0.03% 420
2024
Q1 		$455K Buy
2,295
+23
+1% +$4.21K 0.03% 475
2023
Q4 		$391K Buy
+2,272
New +$349K 0.03% 477
2023
Q3 		– Sell
-1,255
Closed -$274K – 730
2023
Q2 		$274K Sell
1,255
-2
-0.2% -$446 0.02% 545
2023
Q1 		$275K Sell
1,257
-529
-30% -$115K 0.02% 582
2022
Q4 		$372K Buy
+1,786
New +$392K 0.03% 510
2022
Q3 		– Sell
-5,046
Closed -$1.06M – 819
2022
Q2 		$1.06M Buy
5,046
+2,033
+67% +$433K 0.09% 257
2022
Q1 		$731K Sell
3,013
-145
-5% -$35.1K 0.05% 363
2021
Q4 		$823K Sell
3,158
-35
-1% -$9.08K 0.05% 367
2021
Q3 		$842K Buy
3,193
+721
+29% +$197K 0.06% 353
2021
Q2 		$606K Sell
2,472
-348
-12% -$73.2K 0.04% 440
2021
Q1 		$547K Buy
+2,820
New +$565K 0.04% 460

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Financial Advocates Investment Management's RMD Position: Q3 2025 in Review

Financial Advocates Investment Management sold out of ResMed (RMD) in Q3 2025, closing a stake of 2,193 shares — an estimated $566K sold.

Financial Advocates Investment Management first reported a position in RMD in Q1 2021 and held it in 16 quarters. The position peaked at $1.06M in Q2 2022. 950 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • Financial Advocates Investment Management reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
  • Financial Advocates Investment Management sold 2,193 ResMed shares in Q3 2025, an estimated $566K.
  • Financial Advocates Investment Management first reported a position in ResMed in Q1 2021 and held it in 16 quarters.
  • Financial Advocates Investment Management's ResMed position peaked at $1.06M in Q2 2022.
  • 950 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Financial Advocates Investment Management's 13F filing for Q3 2025, filed 6 Nov 2025.